Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01891344
Title A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Acronym ARIEL2
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | FRA | ESP | CAN | AUS


No variant requirements are available.